(Total Views: 581)
Posted On: 05/06/2020 4:18:20 PM
Post# of 154091
Also:
"The elation that Allen felt was soon deflated. Armed with his data, he approached pharmaceutical companies and venture capitalists to launch a study. The expert medical opinion believed that a monoclonal antibody could not be used as treatment. Allen was kicked to the curb."
"I think the hardest part of the journey has been the realities of the medical industry," said Allen, "Big Pharma is risk-averse. They are not interested in innovation, but in selling pills. That was the hardest reality."
"The elation that Allen felt was soon deflated. Armed with his data, he approached pharmaceutical companies and venture capitalists to launch a study. The expert medical opinion believed that a monoclonal antibody could not be used as treatment. Allen was kicked to the curb."
"I think the hardest part of the journey has been the realities of the medical industry," said Allen, "Big Pharma is risk-averse. They are not interested in innovation, but in selling pills. That was the hardest reality."
(2)
(0)
